Overview

Dampening the Reproductive Axis With Continuous Kisspeptin

Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The goal of this study is to assess response to kisspeptin as well as the baseline patterns of luteinizing hormone (LH) secretion in individuals with polycystic ovarian syndrome (PCOS).
Phase:
Phase 1
Details
Lead Sponsor:
Stephanie B. Seminara, MD
Treatments:
Hormones